We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Resources to help anyone developing or running a digital health product to conduct an evaluation.
This page provides information on evaluation for the UK Shared Prosperity Fund.
How to use a cost benefit analysis to evaluate your digital health product.
This document explains the Foreign, Commonwealth & Development Office's aims to generate evaluation evidence, and how we will promote evaluation in the FCDO.
How to use an interrupted time series to evaluate your digital health product.
How to use a cost effectiveness analysis to evaluate your digital health product.
How we evaluated pre-exposure prophylactic (preventative) treatments for COVID-19.
How to use a quasi-experimental study to evaluate your digital health product.
How to use routinely collected data to evaluate your digital health product.
How to use a clinical audit to evaluate your digital health product.
How to use a cost utility analysis to evaluate your digital health product.
This series brings together all documents relating to the Department for Business, Innovation and Skills (BIS) monitoring and evaluation.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey.